Ortho and Palliation Flashcards
Location of bone mets
- Most frequently in axial skeleton (pain may be more diffuse and poorly localized)
- Mets to appendicular skeleton are most common in the femur (2/3 of all path fractures)or humerus (pain may be more discrete)
- Mets are less common in more distal regions
Evaluation of patient with a bone lesion
In patients with a known primary who was thought to be disease free
- Imaging (initial primary, C/A/P/, rest of pelvis)
- Biopsy most accessible site to confirm disease recurrence
CUP and bone lesion
- CT C/A/P to examine viscera for primary or additional mets
- Bone scan for other mets
- Biopsy for histological type
Widely disseminated mets with known diagnosis
- Biopsy unnecessary
- Consider imagining to characterise location
Imaging of patients with metastatic bony disease: UTD Approach
- For suspected extremity lesions, XRs first. If impending or complete pathologic fracture suspected or XRs are ambiguous, consider CT or MRI without contrast to evaluate for surgical stabilization
- In any case where a patient has significant back pain (even without neuro signs) or neurologic symptoms, get a spinal MRI without contrast to rule out cord compression. If symptoms persist but imaging is negative, consider a PET
- Consider a PET scan if:
- Need for comprehensive whole body cancer staging
- Rapidly progressive mets with minimal reactive bone formation
- Ewing sarcoma with primary lytic tumour - If the patient has myeloma
- Primary lytic lesions - get a whole body plain radiograph skeletal survey
- Primary sclerotic lesions - get a bone scan
Imaging of patients with mets to bone: Plain XRs
- Useful to identify overall structural integrity of bone and planning surgical interventions
- Note insensitive for detecting mets (requires minimum lesion diameter of 1cm, bone mineral loss of >50%)
- ‘Moth eaten pattern’ - often with MM, typically more aggressive
- '’Permeative pattern’ - most aggressive
- ‘Geographic pattern’ - slow growing tumours
Imaging of patients with mets to bone: Bone scintigraphy
- Useful to identify other bone lesions through the skeleton
- Detects disease progression ONLY when new bone formation is occurring
- Often false negatives with MM (due to lack of new bone deposition) or highly aggressive mets (e.g. lung CA or Melanoma)
- Sensitivity 75%, poor specificity
Imaging of patients with mets to bone: CT scan
- Useful for assessment of structural integrity
- Helpful for preop planning in the pelvis and spine
- Can identify occult fractures in the setting of a metastatic lesion (more difficult to see on MRI due to marrow edema)
- More useful than plain XR as it better delineates bone involvement and can reveal soft tissue extension
Imaging of patients with mets to bone: MRI
- Provides excellent contrast between normal bone marrow and tumour involved marrow space
- Unable to provide detail regarding structural integrity - typically used in conjunction with plain films and CT scan
- If there is concern re: spine, MRI spine is the most efficient way to assess
Imaging of patients with mets to bone: PET
- PET uses a tracer that shows high uptake in cells with high metabolic activity
- Likely diagnostic potential in metastatic bone disease but cost often prohibitive
Surgical treatment of metastatic bone disease
Goal:
- Increase QOL (decreased tumour burden and pain, improve mobility and function)
- Ultimately goal is immediate WBAT to facilitate quickest return to normal function
Indications for surgery
- Mechanical stabilization
Indications
- Impending or existing pathological fractures (ideally prior to fracture)
- If PS is too poor, or at EOL, casting or splinting may provide mechanical pain relief (but will not improve function)
Casting for patients with metastatic bone disease
- Consider for patients who are too sick/close to EOL for surgery
- Ensure it is well padded and free of any significant areas of pressure so as to avoid skin breakdown/ulceration
- Avoid in limbs with lymphedema (may cause tissue damage or compartment syndrome)
Assessment of fracture risk
- Patients with metastatic lesion at low risk of fracture are often best treated with non-surgical tx (rads, systemic tx)
- Consider use of scoring system for risk of pathologic fracture (Mirels’ scoring system) but may over or under estimate need for surgery
- Evidence to support benefit in terms of QOL is weak
- Surgery has best evidence in patients with a prognosis >6 months, otherwise post-op complications may limit benefit (though patients with short prognosis may still benefit)
Impact of mets on bone biology/biomechanics
Lytic lesions
- Greater removal of mineral/organic components of bone, leading to greater loss in strength and stiffness
- Small osteolytic defects can lead to stress risers (areas of bone where stresses are concentrated around a small hole) and can lead to fracture in cases of pivoting or turning
- Larger metastatic lesions can create a hole in bone larger than the bone’s diameter
Blastic lesions
- No disruption to mineral content of bone but disrupt normal trabecular framework of the cancellous bone
- Lower likelihood of fracture
Factors predicting life expectancy in the context of bony mets
- Multiple bone involvement
- Parenchymal organ involvement
- Low ANC
- Hypoalbuminemia
- Anemia
- Hypercalcemia
*Note this may be biased towards MM natural history
Orthopedic surgical interventions: Tumour excision
- Intralesional excision
- Most common treatment choice
- Provides pain reduction, associated with fewer fixation failures and lower risk of tumour progression at the site - Marginal or wide excision
- Removes the bulk of the tumour by excising at the border of where normal/abnormal tissues meet
- Typically performed in conjunction with arthroplasty
- Can reduce risk of local recurrence and need for further surgery
- More appropriate for patients with long prognosis and an isolated tumour
Orthopedic surgical interventions: Prosthetic joint replacement (arthroplasty)
- Typically knee, hip, shoulder, and elbows
- Resection of one side (hemiarthroplasty) or both sides (total arthroplasty) of the joint surface with prosthetic replacement of the resected joint components
Indications
- Fractures involving the epiphyseal surface of joints (poor healing)
Technical considerations
- Stem of prosthetic component should bypass any distal lesions by twice the diameter of the involved bone to prevent later periprosthetic fracture
- Use cement because the bone ingrowth required for stability with a non-cemented compound is unlikely to ccur